Mytelase

Mytelase is a brand name of ambenonium, approved by the FDA in the following formulation(s):

MYTELASE (ambenonium chloride - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 10MG ^[RLD]

Has a generic version of Mytelase been approved?

No. There is currently no therapeutically equivalent version of Mytelase available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mytelase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Mytelase.

See also...

• Mytelase Consumer Information (Wolters Kluwer)
• Ambenonium Consumer Information (Wolters Kluwer)
• Ambenonium Consumer Information (Cerner Multum)